Randomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as Adjunctive Treatment for MDD

NCT06011577 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

27

Enrollment

INDUSTRY

Sponsor class

Stopped Program Discontinued

Conditions

Major Depressive Disorder
Depression

Interventions

DRUG: REL-1017
DRUG: Placebo

Sponsor

Levomecor Inc.